Header image

Theme A Session 3: Co-morbidities in HIV

Tracks
.
Monday, September 24, 2018
4:00 PM - 5:35 PM
Tuscan (Ground Floor)

Details

Learning Objectives: 1) Understand the prevalence of different co-morbidities in the current cohort of cART-treated individuals. 2) Explore the mechanisms driving the pathogenesis of these diseases. 3) Discuss differences between the pathogenesis and clinical course of these diseases in HIV+ vs the general public.


Speaker

Associate Professor Anthony Jaworowski
Immunologist And Cell Biologist
RMIT university

The current status of non-AIDS cardiovascular comorbidities in HIV disease

4:00 PM - 4:30 PM

Biography

A/PROF Lucette Cysique
Associate Professor
The University Of New South Wales

HIV and ageing of the brain

4:30 PM - 4:45 PM

Abstract

Audio Recording

Speaker Presentation

Biography

A/Prof Anna Hearps
Research Scientist
Burnet Institute

Mechanisms driving increased atherosclerosis risk in people living with HIV on cART

4:45 PM - 5:00 PM

Abstract

Biography

Prof Andrew Carr
Senior Staff Specialist, HIV and Immunology Unit
St Vincent's Hospital, Sydney

Burden of Comorbidities

5:00 PM - 5:15 PM

Audio Recording

Speaker Presentation

Biography

Panel Discussion

Panellists: Stuart Turvillle, Lance Feeney, Anthony Jaworowski, Andrew Carr, Lucette Cysique, and Anna Hearps

5:15 PM - 5:30 PM

Biography


Chair

Lance Feeney
Consultant
Positive Life Nsw

Stuart Turville
Kirby Institute

loading